modelMivacuriumChloride

Diagram of MivacuriumChloride

Extends from Pharmacolibrary.Drugs.ATC.M.M03AC10.

Information

name:MivacuriumChloride
ATC code:M03AC10
route:intravenous
compartments:3
dosage:0.15mg
volume of distribution:0.17L
clearance:4.6ml/min/kg
other parameters in model implementation

Mivacurium chloride is a short-acting, non-depolarizing neuromuscular blocking agent used in anesthesia to induce muscle relaxation, primarily to facilitate tracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation. The drug is approved for clinical use but is not as widely used today due to the availability of alternative agents.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult surgical patients following intravenous bolus and infusion administration.

References

  1. Onrust, SV, & Foster, RH (1999). Rapacuronium bromide: a review of its use in anaesthetic practice. Drugs 58(5) 887–918. DOI:10.2165/00003495-199958050-00011 PUBMED:https://pubmed.ncbi.nlm.nih.gov/10595867

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance
Pharmacolibrary.Types.VolumeVdp2 (from PK_3C)Vdp2PerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdp2PerKg (from PK_3C)0.9Volume of distribution peripheral 2 (l/kg)
Pharmacolibrary.Types.VolumeFlowRatek13 (from PK_3C)1intercompartmental 1-3 clearance (l/min)
Pharmacolibrary.Types.VolumeFlowRatek31 (from PK_3C)1intercompartmental 3-1 clearance (l/min)

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)
Interfaces.ConcentrationPort_bperihperal2Cport (from PK_3C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral2 (from PK_3C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral1 (from PK_3C)
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer1 (from PK_3C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)